“…This approach has since been used to rapidly quantify the number of detergent insoluble inclusions across many in vitro models expressing aggregation-prone proteins, including mutant huntingtin (linked with Huntington's disease) ( Whiten et al, 2016 ) and motor neuron disease-linked proteins SOD1 ( Whiten et al, 2016 ; McAlary et al, 2016 ) and TDP-43 ( Zeineddine et al, 2017a , b ). The application of FloIT has also been expanded to investigate other cellular processes associated with protein aggregation, including induction of a heat shock response ( San Gil et al, 2020 ), the role of molecular chaperones in suppressing protein aggregation ( McMahon et al, 2021 ) and chaperone-assisted selective autophagy ( Adriaenssens et al, 2020 ). Considering that the formation of detergent-insoluble protein aggregates is a disease mechanism common to a wide variety of diseases, including Alzheimer's disease, Parkinson's disease, polyglutamine diseases, such as Huntington's disease and spinocerebellar ataxias, and even type 2 diabetes and dilated cardiomyopathy ( Adriaenssens et al, 2020 ; Chiti and Dobson, 2017 ; Ross and Poirier, 2004 ; Taylor et al, 2002 ; Gidalevitz et al, 2006 ; Mukherjee et al, 2015 ), it is important to determine whether FloIT can be widely adopted to study other proteinopathy disease models.…”